The global Canine Arthritis Treatment Market size was valued at US$ 2.39 billion in 2022. The demand for pharmaceuticals to treat canine arthritis is expected to grow at a CAGR of 4.2%, resulting in a market valuation of US$ 3.05 billion by 2028. Canine arthritis therapy drugs accounted for 17.2% of the global uncommon inflammatory disease treatment market in 2021.
Canine arthritis is a degenerative joint condition that causes inflammation, cartilage degeneration, and long-term joint difficulties in dogs. The knees, elbows, shoulders, hips, and spine are the most typically damaged joints in animals. Some of the causes of canine arthritis in dogs include injuries, obesity, and poor bone development.
Get Sample PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3552
According to Future Market Insights, the global canine arthritis treatment market is expected to grow significantly during the forecast period due to an increase in dog ownership worldwide, the development of veterinary healthcare infrastructure, and the expansion of treatment options for canine arthritis. The increasing prevalence of obesity-induced arthritis in dogs, as well as growing awareness of companion animal health, are driving this growth. Furthermore, the FDA’s ease of approval for new and novel canine arthritis therapy medications will generate chances for market participants to flourish.
Key Takeaways from Canine Arthritis Treatment Market Study
- Nonsteroidal anti-inflammatory medicines are a veterinarian’s first choice for treating inflammation and pain. These drugs have been shown to alleviate tingling, allergic reactions, swelling, and pain. In contrast to non-authorised NSAIDs, canine approved nonsteroidal anti-inflammatory drugs have established a satisfactory safety profile.
- Growth prospects for the canine arthritis market in North America are rather strong when compared to other areas, owing to an increase in canine adoption, increased veterinarian expenditure on their health, and increased pet health awareness.
- Market participants have stayed focused on capitalising on veterinary hospitals and clinics, which provide comprehensive animal care and service support for improved pet health.
- Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.
Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@ https://www.futuremarketinsights.com/ask-question/rep-gb-3552
Competitive Landscape
Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.
Key Players
- Boehringer Ingelheim International GmbH.
- DAIICHI SANKYO COMPANY, LIMITED
- Thorne
- NUTRI-VET
- American Regent, Inc.
- DSM
- Zoetis
- National hog farmer
- Novasep
- Bayer AG
- Matsun Nutrition
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/3552
Key Segments Of Canine Arthritis Treatment Industry Survey
Canine Arthritis Treatment Market by Treatment:
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Opioids
- Stem Cell Therapy
- Allogeneic Stem Cells
- Autologous Stem Cells
Canine Arthritis Treatment Market by Route of Administration:
- Oral Canine Arthritis Treatment
- Injectable Canine Arthritis Treatment
Canine Arthritis Treatment Market by Distribution Channel:
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Drug Stores
- e-Commerce
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
